Core Scientific, Inc.
CORZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5,715 | $5,428 | $2,282 | $4,301 |
| - Cash | $453 | $581 | $698 | $836 |
| + Debt | $1,059 | $1,161 | $1,194 | $1,200 |
| Enterprise Value | $6,321 | $6,008 | $2,778 | $4,665 |
| Revenue | $81 | $79 | $80 | $95 |
| % Growth | 3.1% | -1.1% | -16.2% | – |
| Gross Profit | $4 | $5 | $8 | $5 |
| % Margin | 4.7% | 6.4% | 10.3% | 5% |
| EBITDA | -$127 | -$1 | -$20 | -$235 |
| % Margin | -157.2% | -0.8% | -25.4% | -247.4% |
| Net Income | -$147 | -$937 | $581 | -$266 |
| % Margin | -180.8% | -1,191.4% | 730.2% | -279.7% |
| EPS Diluted | -0.46 | -0.042 | 1.25 | -0.6 |
| % Growth | -1,003.1% | -103.3% | 308.3% | – |
| Operating Cash Flow | $132 | $34 | -$41 | $14 |
| Capital Expenditures | -$255 | -$121 | -$88 | -$29 |
| Free Cash Flow | -$123 | -$87 | -$129 | -$15 |